These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 6223935)

  • 1. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
    Rosenthal SM; Grumbach MM; Kaplan SL
    J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis.
    Egli CA; Rosenthal SM; Grumbach MM; Montalvo JM; Gondos B
    J Pediatr; 1985 Jan; 106(1):33-40. PubMed ID: 3917500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puberty without gonadotropins. A unique mechanism of sexual development.
    Wierman ME; Beardsworth DE; Mansfield MJ; Badger TM; Crawford JD; Crigler JF; Bode HH; Loughlin JS; Kushner DC; Scully RE
    N Engl J Med; 1985 Jan; 312(2):65-72. PubMed ID: 3917301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.
    Reiter EO; Kaplan SL; Conte FA; Grumbach MM
    Pediatr Res; 1975 Feb; 9(2):111-6. PubMed ID: 1090891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular leydig cell hyperplasia as a cause of familial sexual precocity.
    Schedewie HK; Reiter EO; Beitins IZ; Seyed S; Wooten VD; Jimenez JF; Aiman EJ; DeVane GW; Redman JF; Elders MJ
    J Clin Endocrinol Metab; 1981 Feb; 52(2):271-8. PubMed ID: 6780588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L; Jones J; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
    Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis.
    Gondos B; Egli CA; Rosenthal SM; Grumbach MM
    Arch Pathol Lab Med; 1985 Nov; 109(11):990-5. PubMed ID: 3901957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit.
    Reiter EO; Brown RS; Longcope C; Beitins IZ
    N Engl J Med; 1984 Aug; 311(8):515-9. PubMed ID: 6205273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.